By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Syntarga BV 

Toernooiveld 1

Nijmegen    6525 ED  The Netherlands
Phone: 31-24-3652878 Fax:


Start Up

Company News
Aglaia Oncology Announces Sale of Portfolio Company Syntarga BV 6/23/2011 10:50:52 AM
Synthon Acquires Syntarga BV and its Antibody-Drug Conjugate Technology 6/23/2011 10:07:38 AM
Syntarga BV Announces New Antibody-Drug Conjugate Collaborations 4/7/2011 9:37:31 AM
Syntarga BV Announces Additional Antibody-Drug Conjugate Collaborations 6/1/2010 12:42:17 PM
Syntarga BV Announces Two Antibody-Drug Conjugate Collaborations with Top-tier Biopharmaceutical Companies 3/4/2010 2:04:24 PM
Syntarga BV Announces Patent Grant for SpaceLink Technology for Antibody-Drug Conjugation 7/16/2009 12:31:39 PM
Syntarga BV Demonstrates In Vivo Proof of Concept for its Antibody-Drug Conjugate Technology 1/8/2009 12:12:35 PM
Syntarga BV Appoints Antibody-Drug Conjugate expert Dr. Nitin Damle as Advisor 7/21/2008 2:28:03 PM
Syntarga BV Licenses Potent Cell-Killing Drugs From The University Of Göttingen, Germany 3/15/2006 2:07:59 PM
Syntarga BV Closes Series A Financing10/19/2005 5:12:42 PM